Related Experiment Video
Updated: Aug 2, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Les 'Lignes Directrices Pour l'Usage du Cannabis à Moindre Risque (LUCMR)': RECOMMENDATIONS [The 'Lower-Risk Cannabis
Benedikt Fischer1, Tessa Robinson2, Chris Bullen3
1Schools of Population Health and Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand; Centre for Applied Research in Mental Health and Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil.
No abstract available in PubMed .
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drug Classes and Categories
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Stress Prevention and Stress Management Techniques IV
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Pre-Procedural Guidelines for Assessing Blood Pressure

